Jirō Ikeda

Excision repair cross‐complementation group 1 predicts progression‐free and overall survival in non‐small cell lung cancer patients treated with platinum‐based chemotherapy

Koichi Azuma, Yoshihiro Komohara, Tetsuro Sasada et al. · Cancer Science · 2007 · 99 citations · Full text

Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel

Koichi Azuma, Tetsuro Sasada, Akihiko Kawahara et al. · Lung Cancer · 2008 · 82 citations

Class Iii β-Tubulin, Medicine, Cancer Cell Biology +8

Serum carcinoembryonic antigen as a predictive marker for sensitivity to gefitinib in advanced non-small cell lung cancer

Tatsuro Okamoto, Tomomi Nakamura, Jirō Ikeda et al. · European Journal of Cancer · 2005 · 57 citations

Prognostic Biomarkers, Medicine, Pathology +9

Induction chemoradiotherapy and surgical resection for selected stage IIIB non–small-cell lung cancer

Yukito Ichinose, Yasuro Fukuyama, Hiroshi Asoh et al. · The Annals of Thoracic Surgery · 2003 · 43 citations

Surgical Oncology, Surgical Resection, Medicine +9

Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation

Koichi Azuma, Tetsuro Sasada, Akihiko Kawahara et al. · Cancer Chemotherapy and Pharmacology · 2009 · 37 citations

Radiation Therapy, Class Iii β-Tubulin, Medicine +8